Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring
Award Notice Posted
- Solicitation number
- PHS-2021-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Zymeron Corporation
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93021C00030 Federal contract award
- Place of performance
- Durham, North Carolina 27709, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Zymeron Corporation has been awarded a fixed price contract valued at $299,988 by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to develop a rapid point of care test to quantify levels of HIV drugs in patients to help ensure effectiveness of antiretroviral therapy and assist those with HIV and medical professionals in monitoring medication adherence under contract number 75N93021C00030 awarded on July 1, 2021.
Notice text
Awarded contract 75N93021C00030 to Zymeron Corporation for 299988.00 on 2021-07-01.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity